Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2362 of 5804
-
New RNA drug hopes to slow duchenne muscle loss
Disease control OngoingThis is an open-label, single-arm, dose-escalation trial to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of RAG-18 in pediatric patients with Duchenne Muscular Dystrophy (DMD). The study will enroll approximately 12 su…
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New online CBT shows promise for anxious kids and teens
Symptom relief Recruiting nowThe goal of this study is to develop a new internet-delivered cognitive behavioral therapy (ICBT) intervention for youths with anxiety disorders based on the best current knowledge about effective cognitive behavioral therapy for the target group, refine the intervention in colla…
Phase: NA • Sponsor: Lund University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New pill aims to calm gallbladder pain without surgery
Symptom relief Recruiting nowThe aim of the study is to evaluate the efficacy, safety, and tolerability of 4-MUST, 128 mg tablets compared to placebo in patients with chronic cholecystitis and biliary dyskinesia.
Phase: PHASE3 • Sponsor: Valenta Pharm JSC • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Mulberry leaf extract tested for menopause symptom relief
Symptom relief Recruiting nowThe purpose of this double-blind, randomized, placebo-controlled trial is to. evaluate daily Reducose® (mulberry leaf extract) supplementation taken with the two largest meals for 12 weeks on improving glycemic response and perimenopausal symptoms in women aged 40-60 years. Glyce…
Phase: NA • Sponsor: Phynova Group Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New insulin pump shows promise for type 2 diabetes control
Disease control CompletedThis is a single arm feasibility study to evaluate the Omnipod M System in adults with Type 2 Diabetes with the aim to enroll to 40 participants aged 18-75 years with type 2 diabetes to have a minimum of 20 participants initiate the use of Omnipod M System and the goal of 16 part…
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a remote breathing workout boost strength and life quality in MS?
Symptom relief CompletedThe main objective of the present study is to verify whether respiratory muscle training programme (IMT+EMT; included both inspriratory and expiratory muscles with load adjustment based on the principles of the 1-repetition maximum (RM) test), applied by telerehabilitation, is an…
Phase: NA • Sponsor: Tamara del Corral Núñez-Flores • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Mucus mystery: new study aims to uncover role of airway blockages in lung disease
Knowledge-focused Recruiting nowChronic lung diseases affect one in five Canadians, causing symptoms such as cough, breathlessness, and wheeze. Despite advancements in medical care, these conditions not only impact individuals and their close circles but also present substantial clinical and economic challenges…
Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Can neck exercises boost stroke recovery? new study investigates
Disease control ENROLLING_BY_INVITATIONStroke is a neurological event that leads to significant motor and functional impairments due to disruption of cerebral blood flow. The subacute phase, typically ranging from day of attack up to three months post-stroke, is a critical window for neuroplasticity and functional rec…
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Study reveals cannabis users may need more anesthesia during spine surgery
Knowledge-focused ENROLLING_BY_INVITATIONCannabis is the most commonly used illicit drug in the United States with reported rates of use increasing from approximately 50 million in 2020 to 61.8 million in 2023 among individuals aged 12 or older. This rise can be attributed to a combination of growing social acceptance a…
Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New study tests Muscle-Saving drink for GLP-1 weight loss patients
Symptom relief Recruiting nowThis study evaluates whether a Food for Special Medical Purposes (FSMP) can help to preserve appendicular skeletal muscle mass (ASMM) in adults undergoing weight loss treatment with GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists. Participants will receive the FSMP or…
Phase: NA • Sponsor: Pharmanutra S.p.a. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Simple leg test could rival injections for diagnosing nerve pain
Diagnosis Recruiting nowThis study aims to evaluate the diagnostic accuracy of the straight leg raise test in patients with suspected lumbosacral radicular pain. Lumbosacral radicular pain is often caused by lumbar disc herniation and may radiate from the lower back or buttock to the leg. Although the s…
Sponsor: Marmara University • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo shows promise in early cancer trial
Disease control Recruiting nowThe purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-75098 alone and in combination with BGB-43395 and fulvestrant in participants with advanced solid tumors.
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Giant cell arteritis patients may be able to reduce treatment, study suggests
Disease control Recruiting nowThis is a multi-center, randomized, open label study that will assess the efficacy and safety of ACTEMRA(R) or one of its FDA-approved biosimilars Tocilizumab (TCZ) maintenance versus withdrawal in Giant cell arteritis (GCA) patients who are in remission after at least 12 months …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Simple enema may shield rectal cancer patients from radiation side effects
Prevention Not yet recruitingResearch Objective and Principle: To evaluate the effectiveness of Bergmann enema in preventing acute radiation-induced rectal injury in patients with rectal cancer, thereby providing a basis for treatment options for potential radiation-induced rectal injury patients, aiming for…
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Brain scans may predict who will respond to psychosis treatment
Knowledge-focused Recruiting nowResearchers propose in this project to evaluate predictive factors of non response. It is defined by the lack of symptomatic remission at month 3, for patients presenting a first episode of psychosis. It will be performed on objective markers taken from imagery techniques. The li…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Smart tracking may boost kidney stone shockwave success
Symptom relief Recruiting nowExtracorporeal shockwave lithotripsy (ESWL) is a non-invasive standard treatment for kidney stones. This study will be conducted to evaluate the effectiveness of ESWL using MODULITH® SLX-F2 with stone tracking, compared to MODULITH® SLX-F2 without stone tracking, in adult patien…
Phase: NA • Sponsor: Storz Medical AG • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Mindfulness boosts Well-Being and adherence in dialysis patients
Symptom relief CompletedChronic kidney disease (CKD) and its treatment with hemodialysis pose significant challenges to patients' psychological well-being and adherence to complex treatment regimens. This randomized controlled trial investigated the effects of nurse-led, mindfulness-based interventions …
Phase: NA • Sponsor: Baskent University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New pill shows promise in early cancer trial
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-75202 (KAT6A/B inhibitor) alone and in combination with other therapies in participants with breast cancer and other advanced solid…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Heart patients get smarter cholesterol care with Algorithm-Guided team approach
Disease control Recruiting nowThis is a randomized, controlled, collaborative, multicenter, pilot implementation science study evaluating the hypothesis that algorithm- and multi-professional team-supported lipid management reduces low density lipoprotein-cholesterol (LDL-C) compared with usual care in patien…
Phase: NA • Sponsor: Colorado Prevention Center • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for COPD patients with high lung blood pressure?
Disease control Not yet recruitingStudy Title: A Clinical Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension in Patients With Chronic Obstructive Pulmonary Disease (HOLLYWOOD) The goal of this clinical study is to learn if the inhaled drug iloprost is effective and safe for treating pulmonary …
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC